Celldex Therapeutics (CLDX) Q4 2013 Earnings

8NovConfirmed
Mar 13
May 13
Q3 2013
Q4 2013
-4.35
-4
-3.65
-3.3

Details

Expected EPS
N/A
Actual EPS
-4.35
Surprise EPS
-4.35
Surprise Percent
+∞%

Description

Celldex Therapeutics (CLDX) has reported earnings of -4.35 per share for Q4 2013.

0 Comments

Share your thoughts